![Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1697af5f-871c-405d-895d-823bd582e940/gr1.jpg)
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings - Annals of Oncology
![bcl-2 expression in head and neck cancer: an enigmatic prognostic marker - International Journal of Radiation Oncology, Biology, Physics bcl-2 expression in head and neck cancer: an enigmatic prognostic marker - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2004837540/2020461466/gr1.gif)
bcl-2 expression in head and neck cancer: an enigmatic prognostic marker - International Journal of Radiation Oncology, Biology, Physics
PLOS ONE: Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
![Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia - The American Journal of Emergency Medicine Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia - The American Journal of Emergency Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2003103380/2012298344/gr1.jpg)
Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia - The American Journal of Emergency Medicine
![Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma - EBioMedicine Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma - EBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/19c64454-691f-45fb-ab0d-7332e75ae08d/gr1.jpg)
Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma - EBioMedicine
PLOS ONE: PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
![CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study | Epidemiology & Infection | Cambridge Core CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study | Epidemiology & Infection | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20201019185757307-0048:S0950268820002368:S0950268820002368_fig3.png?pub-status=live)
CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study | Epidemiology & Infection | Cambridge Core
![K17, a prognostic marker in cervical cancer independent of tumor stage.... | Download Scientific Diagram K17, a prognostic marker in cervical cancer independent of tumor stage.... | Download Scientific Diagram](https://www.researchgate.net/profile/Kenneth-Shroyer/publication/282475832/figure/fig1/AS:281668712714245@1444166462921/K17-a-prognostic-marker-in-cervical-cancer-independent-of-tumor-stage-A-hematoxylin.png)
K17, a prognostic marker in cervical cancer independent of tumor stage.... | Download Scientific Diagram
![Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD | American Society of Nephrology Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/28/9/2802/F1.large.jpg)
Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD | American Society of Nephrology
![COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome - Journal of the Neurological Sciences COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b4d52a0d-5176-426d-99c7-dbe6cddc93e3/gr1.jpg)
COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome - Journal of the Neurological Sciences
![Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6604999/MediaObjects/41416_2009_Article_BF6604999_Fig1_HTML.gif)
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer
![Systematic review: prognostic tests of paracetamol‐induced acute liver failure - CRAIG - 2010 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Systematic review: prognostic tests of paracetamol‐induced acute liver failure - CRAIG - 2010 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2610e38d-cf80-4e34-9110-85d9fff702f0/apt_4279_f1.gif)
Systematic review: prognostic tests of paracetamol‐induced acute liver failure - CRAIG - 2010 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy - Radiotherapy and Oncology Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f6c15e8c-c66b-4c55-a6fd-ceb81ba98444/gr1.jpg)
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy - Radiotherapy and Oncology
![Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial - European Journal of Cancer Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/42c076b9-e534-4b40-bdbc-343bb3f8ced3/gr1.jpg)
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial - European Journal of Cancer
Current and future biomarkers for risk-stratification and treatment personalisation in multiple myeloma - Molecular Omics (RSC Publishing)
![2 Breast cancer metastasis prognostic markers. Reprinted by permission... | Download Scientific Diagram 2 Breast cancer metastasis prognostic markers. Reprinted by permission... | Download Scientific Diagram](https://www.researchgate.net/profile/Douglas-Kniss/publication/265261050/figure/fig2/AS:669486294261761@1536629379081/Breast-cancer-metastasis-prognostic-markers-Reprinted-by-permission-from-Macmillan.jpg)
2 Breast cancer metastasis prognostic markers. Reprinted by permission... | Download Scientific Diagram
![SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/14ffb86d-5d06-4b9a-87a4-40b5eb05972c/fx1_lrg.jpg)
SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDY - Canadian Journal of Cardiology
![Almost all articles on cancer prognostic markers report statistically significant results - European Journal of Cancer Almost all articles on cancer prognostic markers report statistically significant results - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f59b4b90-5207-438a-99aa-056c017bc4a0/gr1_lrg.jpg)
Almost all articles on cancer prognostic markers report statistically significant results - European Journal of Cancer
![Ki67 as a prognostic marker in uterine leiomyosarcoma: a quantitative systematic review - European Journal of Obstetrics and Gynecology and Reproductive Biology Ki67 as a prognostic marker in uterine leiomyosarcoma: a quantitative systematic review - European Journal of Obstetrics and Gynecology and Reproductive Biology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8b765089-1420-4373-ba14-1d9110a8b909/gr1.jpg)
Ki67 as a prognostic marker in uterine leiomyosarcoma: a quantitative systematic review - European Journal of Obstetrics and Gynecology and Reproductive Biology
![Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/7/3947/F1.large.jpg)